Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eggleton

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Thrombosis Research|January 1, 1978
Anticoagulant activities of lung and mucous heparinsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
British Journal of Haematology|April 1, 1979
Anticoagulant activities of high and low molecular weight heparin fractionsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
The Science of the Total Environment|January 25, 2022
Spatial and temporal patterns of heavy metals and potential human impacts in Central Yangtze lakes, ChinaRui Wang, Wentong Xia, Michael A Eggleton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Genetic variants in the vitamin D receptor gene and prostate cancer riskVanessa M Hayes, Gianluca Severi, Emma J D Padilla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopeciaVanessa M Hayes, Gianluca Severi, Sarah A Eggleton, et al.
Journal of the National Cancer Institute|October 5, 2006
Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomySusan M Henshall, Lisa G Horvath, David I Quinn, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSAGianluca Severi, Vanessa M Hayes, Petra Neufing, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Thrombosis Research|January 1, 1978
Anticoagulant activities of lung and mucous heparinsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
British Journal of Haematology|April 1, 1979
Anticoagulant activities of high and low molecular weight heparin fractionsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
The Science of the Total Environment|January 25, 2022
Spatial and temporal patterns of heavy metals and potential human impacts in Central Yangtze lakes, ChinaRui Wang, Wentong Xia, Michael A Eggleton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Genetic variants in the vitamin D receptor gene and prostate cancer riskVanessa M Hayes, Gianluca Severi, Emma J D Padilla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopeciaVanessa M Hayes, Gianluca Severi, Sarah A Eggleton, et al.
Journal of the National Cancer Institute|October 5, 2006
Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomySusan M Henshall, Lisa G Horvath, David I Quinn, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSAGianluca Severi, Vanessa M Hayes, Petra Neufing, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Pageof 2